Add BrightSurf on Google Email

Study discovers new method of classifying low-grade brain tumors

A new classification system has been developed to improve the diagnosis and treatment of low- and intermediate-grade gliomas (LGGs), reducing the reliance on subjective tumor appearance. The system uses molecular and genetic analysis to identify three distinct groups of LGGs with varying prognoses, offering a more objective approach.

SourceUniversity Hospitals Cleveland Medical Center·JournalNew England Journal of Medicine·DateJun 10, 2015

New tactic targets brain tumors

A new study from Rice University suggests that therapies targeting the insulin signaling pathway in brain tumors may be ineffective if they target the wrong molecules. Researchers found that glioblastomas, the deadliest form of brain cancer, have a complex relationship with insulin and other growth factors.

SourceRice University·JournalPLOS Computational Biology·DateApr 20, 2015

Stem cells lurking in tumors can resist treatment

Researchers have discovered that slow-growing brain cancer stem cells are resistant to treatment and can survive stress by producing a protein called Abcg1. The study suggests that using different drugs and higher dosages may be necessary to target these treatment-resistant stem cells.

SourceWashU Medicine·JournalCell Reports·DateMar 12, 2015

Plant extract fights brain tumor

A novel, non-invasive treatment strategy for Cushing Disease has been discovered using silibinin from milk thistle seeds. The active compound binds to heat shock protein 90, allowing glucocorticoid receptor molecules to dissolve and restore normal ACTH production.

SourceMax-Planck-Gesellschaft·JournalNature Medicine·DateFeb 11, 2015

New study identifies first gene associated with familial glioma

Researchers have identified a gene associated with familial glioma, suggesting that certain individuals may be genetically predisposed to the disease. The POT1 gene mutation is linked to lower-grade oligodendroglioma, which is more sensitive to radiation therapy, and raises hopes for improved treatments and preventive strategies.

SourceBaylor College of Medicine·JournalJNCI Journal of the National Cancer Institute·DateDec 7, 2014

New cause of child brain tumor condition identified

A new study has identified the SUFU gene mutation as a major contributor to Gorlin syndrome-associated childhood medulloblastoma, significantly increasing the risk of brain tumors in children with this condition. This finding has major implications for treatment and screening protocols for children with Gorlin syndrome.

SourceUniversity of Manchester·JournalJournal of Clinical Oncology·DateDec 2, 2014

Radiation a risk factor for brain tumors in young people

A Loyola University Medical Center study has found radiation to be a risk factor for the development of meningiomas, a type of brain tumor, in individuals under age 30. The study analyzed records of patients diagnosed with meningiomas before age 30 and found that five had been exposed to ionizing radiation earlier in their lives.

SourceLoyola Medicine·JournalNeuroscience Discovery·DateNov 4, 2014